Product Information
BYSTOLIC 10 MG TABLET is a brand product labeled by Allergan, Inc., priced at $5.8383 per EA under NDC 00456141030. Its NADAC has been published 573 times since Nov 28, 2013.
FDA first approved this application on Dec 17, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Allergan, Inc.NDC
00456141030
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
10/23/2024
Active Ingredients
NEBIVOLOL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021742FDA Approved
12/17/2007
TE Code
AB
On Market Since
1/22/2008
Pharmacological Classes
Price Statistics
The NADAC for BYSTOLIC 10 MG TABLET has been published 573 times since Nov 28, 2013, and over the history we have for it it has risen 146.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.8383 per EA |
|---|---|
| All-time high | $5.8578 (May 15, 2024) |
| All-time low | $2.3721 (Nov 28, 2013) |
| Median price | $4.5867 |
| Average price | $4.3535 |
| Largest weekly change | +9.5% (Jan 9, 2019) |
| Weeks tracked | 573 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+4.9%
5Y
+15.6%
All
+146.1%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
nebivolol hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BYSTOLIC 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BYSTOLIC 10 MG TABLET, manufactured by Allergan, Inc., is $5.8383 per EA (NDC 00456141030), effective Nov 13, 2024.
How has the price of BYSTOLIC 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for BYSTOLIC 10 MG TABLET has risen 146.1%. It has been tracked across 573 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BYSTOLIC 10 MG TABLET?
Since Nov 28, 2013, the NADAC for BYSTOLIC 10 MG TABLET has ranged from a low of $2.3721 (Nov 28, 2013) to a high of $5.8578 (May 15, 2024), with a median of $4.5867 per EA.
Are there cheaper alternatives to BYSTOLIC 10 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NEBIVOLOL 10 MG TABLET, is $0.1414 per EA — about 98% below BYSTOLIC 10 MG TABLET.
Who manufactures BYSTOLIC 10 MG TABLET?
BYSTOLIC 10 MG TABLET (NDC 00456141030) is labeled by Allergan, Inc., and CMS classifies it as a brand product.